HGM2018 Abstract Submission Guidelines
Each registrant may submit abstract(s) of his/her work for presentation during the Human Genome Meeting 2018. It is expected that the abstract will include original data not previously published in a peer-review journal or the proceedings of a national meeting.
Only those abstracts that have been reviewed and selected by the Abstract Review Committee may be presented. Abstract submissions will only be accepted electronically through the abstract submission module; paper abstracts will not be accepted.
The abstract submission deadline is December 17, 2017
Important Dates & Deadline
|Opening of abstract submissions||September 1, 2017|
|Abstract submissions close||December 17, 2017|
- Symposium 1 - Cancer Genomics and Immuno-oncology
- Symposium 2 - Integration of Large Datasets
- Symposium 3 - Single Cell Biology
- Symposium 4 - Data Sharing for Personalized Medicine
- Symposium 5 - DNA Damage and Replication
- Symposium 6 - Human Development
- Symposium 7 - OECD Session (Microbiome)
- Symposium 8 - HVP Session (Human Variome Project)
- Symposium 9 - Genome Editing
- Symposium 10 - Anatomy of the Human Genome (RIKEN session)
- Symposium 11 - Population and Evolutionary Genetics
- Symposium 12 - Model Organisms for Human Diseases
All abstracts must be submitted online through the abstract portal.
- Abstracts must be prepared in English only
- Abstracts sent by fax or post will not be accepted
- The text should not exceed 400 words
Authors who submit an abstract of a paper confirm that they have not previously published these data, that they have not previously presented them at a large national annual scientific meeting, and that they are not planning to present or publish them prior to the dates of this HGM2018.
The Abstract Review Committee will evaluate the scientific quality of the submitted abstract on the basis of the following criteria: novelty of the research, significance of the findings, and clarity.
Authors should be particularly cognizant of the importance of setting forth the objectives and hypotheses of the study in a clear, succinct manner and of summarizing the new, unpublished results. If the abstract is poorly written such that the Abstract Review Committee cannot determine its novelty and importance, the paper will not be accepted for presentation at the meeting.
Authors submitting abstracts for presentation at this meeting should consider the followings: abstracts must describe in a succinct manner the purposes and results of the research so that the quality, originality and comprehensiveness of the work can be evaluated by the International Scientific Committee.
Titles should be indicative of the content of the abstract. All words necessary to identify the subject matter should be included in the title to facilitate electronic retrieval (if applicable). Avoid nonstandard abbreviations in abstract titles.
Abbreviations may be used in the body of an abstract if they are defined at their first mention in the text.
Trade names and drug brand names should be avoided.
The combined length of the abstract body should not exceed 400 words. The online submission module will not accept abstracts that exceed this word limit.
The accuracy of the submitted abstract is the responsibility of the authors. Every effort will be made to publish the abstract exactly as submitted. Authors should prepare and proofread their abstracts carefully prior to submission. Errors made on your submitted abstract are likely to appear in print.
Authors are strongly encouraged to print a hard copy of their abstract for their records before submitting.
The Abstract Review Committee will select available numbers of abstracts as Oral Presentation to be presented during scientific sessions.
For those who wish to present their abstracts in ‘RIKEN trainee symposium’ on Monday 12 March 2018, please select trainee symposium option while submission. As there will be awards for best oral presenters, those who chose to present at RIKEN trainee symposium must show up to receive the awards.
Detailed information on the duration and timing of the presentation will be emailed to all delegates whose abstracts have been accepted by the Abstract Review Committee.
Printed Poster to be created by the submitter and affixed in the poster panels.
Detailed information on the presentation format and submission procedures (i.e duration and timing of the presentation, size of poster, accepted file type for digital poster, uploading information etc.) will be emailed to all delegates whose abstracts have been accepted by the Abstract Review Committee.
Abstracts selected for presentation during the conference will be printed from the electronically submitted material. Every effort should be made to reproduce the content of the abstracts as submitted. However, please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting. The Abstract Review Committee does not proof-read or correct spelling, typographical, grammatical, or scientific errors, nor can changes be made once the abstract is submitted.
All PRESENTERS must register to attend the HGM2018 and presenters will not be given a poster number slot until full payment is received for their registration.
If an abstract is accepted and the PRESENTER does not register, the abstract may be withdrawn.
By submitting an abstract, the submitting author authorizes the abstract to be published by HUGO in the means it deem fit.
After the abstracts have been submitted, a confirmation of receipt will be sent via e-mail. Notifications of abstract receipt will be sent to the ABSTRACT SUBMITTER only. Once an abstract has been submitted, it may be withdrawn or edited only till the abstract submission deadline.
Notification of Abstract Status
Abstract presenters will be notified by e-mail by end-February 2018. Notices and instructions will be sent to the e-mail address provided at the time of abstract submission.
For abstract enquiries, kindly email us at email@example.com